Technology / Scientific & Technical InstrumentsBSE
$518.55
+26.05 (+5.29%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-19.1M · quality 45.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
65/100
B
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$20.0B
P/E
24.6x
↑EV/EBITDA
13.5x
↑ROE
10.9%
↑Gross Margin
62.1%
↑Debt/Equity
0.11
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+11.3%
FCF CAGR
—
FCF margin
-0.2%
FCF / Net income
-0.02x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $7.75B · net income $815.3M · FCF $-19.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.75B | $7.75B | $7.20B | $6.79B | $5.63B |
| Net Income | $815.3M | $815.3M | $224.0M | $396.6M | $468.2M |
| EBITDA | $1.47B | $1.47B | $629.5M | $826.4M | $849.5M |
| EPS | 21.07 | 21.07 | 5.84 | 10.54 | 12.33 |
| Gross Margin | 62.1% | 62.1% | 58.2% | 55.2% | 52.4% |
| Operating Margin | 11.7% | 11.7% | 2.9% | 6.5% | 10.0% |
| Net Margin | 10.5% | 10.5% | 3.1% | 5.8% | 8.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.11 | 0.11 | 0.16 | 0.10 | 0.26 |
| Current Ratio | 3.02 | 3.02 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-19.1M | $-19.1M | $-112.4M | $70.4M | $-27.5M |
| Returns | |||||
| ROE | 10.9% | 10.9% | 3.7% | 7.1% | 11.7% |
| Valuation | |||||
| P/E | 24.60 | 24.60 | 39.17 | 43.78 | — |
| EV/EBITDA | 13.53 | 13.53 | 14.06 | 21.10 | — |
| P/B | 2.69 | 2.69 | 1.44 | 3.11 | — |
| Growth & Yield | |||||
| Revenue Growth | 7.6% | 7.6% | 6.1% | 20.7% | — |
| EPS Growth | 260.8% | 260.8% | -44.6% | -14.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
29.7%
EPS terminal req.
$46.01
Spread vs growth
231.0%
5Y implied EPS CAGR
21.5%
EPS terminal req.
$55.68
Spread vs growth
239.3%
10Y implied EPS CAGR
15.6%
EPS terminal req.
$89.67
Spread vs growth
245.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+73.8%
Start / end P/E
51.1x → 24.6x
EPS bridge
5.84 → 21.07
Residual
-135.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.